Artwork for podcast Building Biotechs
Networking, Collaboration, and the Dynamics of Business Growth with Padma Kodukula, Chief Business Officer at A-Alpha Bio
Episode 1917th January 2024 • Building Biotechs • Recruitomics Consulting
00:00:00 00:45:06

Share Episode

Shownotes

In this episode, we chat with Padma Kodukula, Chief Business Officer at A-Alpha Bio,  a company that leverages synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions. Padma has guided life sciences companies to an aggregate $15B+ in capitalization, as well as numerous product launches and strategic acquisitions. 

Topics we Discuss:

  • Collaborations with diverse entities, from larger pharma companies to academic institutions
  • The significance of networking and building connections in career transitions
  • Effective communication strategies within hybrid work environments
  • Insights into the process of seeking funding and essential components required for a compelling pitch
  • Approaches to business growth and culture

Connect with us!

Link In with Carina

Subscribe here:


Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

Transcripts

Speaker:

Padma Khadakulla is the chief business officer at

Speaker:

A-Alpha Bio, and she has a fascinating career journey. But

Speaker:

what I took away from the conversation was a lot about her passion for

Speaker:

mentorship and her passion for helping companies to really figure

Speaker:

out how to sell themselves, whether they are selling a product

Speaker:

Padma has a really interesting career history and she brought

Speaker:

so many cool insights to the table. If you are someone who loves

Speaker:

networking, Padma also loves networking and she really

Speaker:

She has the real extrovert energy going. I

Speaker:

Yes, absolutely. So anyone who's interested in being a

Speaker:

chief business officer or wonder about how business development gets

Speaker:

done in a biotech, this is really your episode. We

Speaker:

dive pretty deep into a lot of what she does on a daily basis in

Speaker:

that realm. All right, well Padma, thank you so much for joining us today.

Speaker:

We start all of our podcast episodes pretty

Speaker:

much in the same way, which is by asking what did you want to be when you were seven?

Speaker:

Yeah, when I was seven, I wanted to be a teacher. I

Speaker:

was enamored, I was inspired by some of my early

Speaker:

teachers. I loved school. And then as

Speaker:

I moved on for high school, I

Speaker:

loved education. So I wanted to learn more and

Speaker:

hence my journey to do a bachelor's and then a master's and

Speaker:

then a PhD. And so I wanted to study

Speaker:

as long as I could, go as high as I could. And

Speaker:

then I think five years of PhD ultimately got

Speaker:

the realization that, okay, I've studied everything that I could

Speaker:

and this was going to be a lifelong process. It doesn't have to be degrees, but

Speaker:

I will be studying and learning all my life. But I

Speaker:

don't think I want to do bench science as much. It's a

Speaker:

very lonely field. And I came

Speaker:

to the realization that I enjoy being in teams more.

Speaker:

than doing my own research by the bench for years to

Speaker:

come. And so I really moved right after my PhD into

Speaker:

a postdoc and really moved. And back in the day in the

Speaker:

1990s, that was a big deal. People did postdocs, people stayed in academia. You

Speaker:

didn't move to industry. But I decided that I was going

Speaker:

to move to industry and not do basic science or research

Speaker:

and really jumped into project program management and

Speaker:

have been teams. And then from there I moved to this step. So it's

Speaker:

been a long journey, but my love for science, my love

Speaker:

That's great. We hear a lot of awesome career journeys and none

Speaker:

of them are linear. So I think that that's a real takeaway is,

Speaker:

you know, there's a lot of things that we in our company is also like

Speaker:

this. We are science adjacent, right? We're still very close to it, but we're not at the bench

Speaker:

anymore. And there's so many career paths that can be like that. How

Speaker:

did you end up then in business development? That does seem like a little bit

Speaker:

of a shift from project management to business development. Can you walk us

Speaker:

So I started again from my PhD where

Speaker:

I was defending my own experiments and designing my own experiments

Speaker:

to really a technical services scientist where I

Speaker:

was defending other people's experiments and supporting them

Speaker:

with their experiments. But there for a year really gave

Speaker:

me an opportunity to see all technologies and all programs

Speaker:

within the company. And then I picked one of the programs to become a program manager

Speaker:

for that company. I was there for 10 years and that gave

Speaker:

me a phenomenal opportunity to really take multiple

Speaker:

ideas from early stage to launch. And,

Speaker:

you know, I am talking research reagents, which were very quick.

Speaker:

You could put them out there in six months to diagnostics, which

Speaker:

took two to three years to put out there. And therapeutic, right?

Speaker:

I was part of Sutent, which was just finishing

Speaker:

its phase three clinical trial at Pfizer and was

Speaker:

being submitted for a therapeutic product for renal cell

Speaker:

carcinoma. So I was part of that team. So I really saw that trajectory. So

Speaker:

I was very excited about all, I mean, you get to see the whole multitude

Speaker:

of departments and functions that have to come together from marketing, to

Speaker:

manufacturing, to R&D, to quantity, to everybody else

Speaker:

to take a product from idea to commercial. And

Speaker:

so that was all very exciting. Did that a lot, did it across multiple

Speaker:

industries and multiple companies. And then I was

Speaker:

fascinated with business development because you represent a

Speaker:

company with the technology and you go make deals, deals were

Speaker:

very fascinating for me. And I liked the

Speaker:

ability to take all the science and represent the company

Speaker:

for partnerships. And I was actually managing, I went from project

Speaker:

management to doing Alliance management and Alliance manager

Speaker:

does where I work closely with BD and once they signed the deal, they

Speaker:

would put it with me and I was responsible for executing that

Speaker:

deal. So that was my connection between project management to

Speaker:

BD and Alliance management, you know, yeah, I

Speaker:

started itching more and more to do the deals myself. Right.

Speaker:

Rather than execute on a deal that was done. And so the

Speaker:

And so now you are the chief business officer at A-Alpha Bio.

Speaker:

Can you walk us through what like maybe a day in

Speaker:

the life looks like in that job? I'm sure every day is different, but

Speaker:

on a standard-ish day, how would you describe what you do?

Speaker:

We wear multiple hats, I wear multiple hats at A

Speaker:

Alpha Bio, and it's all about value creation

Speaker:

for early stage companies. And you do that

Speaker:

with science. And so I am very involved with the

Speaker:

chief technology officer, with the R&D scientists to

Speaker:

really understand what science we are doing, to explore where

Speaker:

else we need to go. And so I'll sit in many R&D meetings

Speaker:

to soak in the science, to give them feedback on what the

Speaker:

market needs and where are we going down

Speaker:

rabbit holes and what is very relevant. I also do

Speaker:

a lot of outside like market intelligence, business intelligence

Speaker:

to know what are my competitors doing? What deals were signed today?

Speaker:

I certainly link it in quite a bit to understand all the science

Speaker:

and all deals that I made. So that's market intelligence, business intelligence.

Speaker:

And then I'm always connecting with my BD partners in

Speaker:

pharma companies, small biotech companies. Maybe at any point

Speaker:

in time, I'm looking at 40, 50 companies that

Speaker:

I want to connect with. And so part of my day

Speaker:

is also, you know, reaching out to some of these, responding to

Speaker:

them. We may have multiple early stage discussions, which

Speaker:

are always ongoing. So a lot of follow ups, right? I'm

Speaker:

connecting with R&D to get new staff, connecting with my external

Speaker:

BD folk. planning meetings, strategically planning

Speaker:

areas and planning meetings. So I would say my

Speaker:

day is usually meetings. I would say three, four

Speaker:

meetings, a lot of thinking and strategizing for

Speaker:

the future. Do that and lots of follow ups. Stuff that

Speaker:

you know maybe they need to be pinned one more time they were supposed to get me

Speaker:

something and right or planning for so I

Speaker:

like it because it's actually I would say equal parts strategy

Speaker:

and equal parts implementation that's awesome so.

Speaker:

Can you give us a high-level overview of A-Alpha Bio? I

Speaker:

am so enamored by the synthetic biospace. And so if you could tell

Speaker:

So we are a spin-out of University of Washington Institute

Speaker:

for Protein Design, and we have a wet lab platform and

Speaker:

a dry lab platform. The wet lab is a yeast platform,

Speaker:

a synthetic biology platform, where we can measure

Speaker:

quantitatively millions of protein-protein interactions

Speaker:

in a single experiment. And this is, again,

Speaker:

the synthetic biology that allows you two weeks or

Speaker:

less to look at such a large scale of protein interactions.

Speaker:

And then we can take all that data, put it into machine learning,

Speaker:

our dry lab platform to train machine learning

Speaker:

models, validate them and use them to predict

Speaker:

additional biologics or protein structures

Speaker:

or protein sequences. So yeah, and you can do

Speaker:

multiple iterations of the wet lab and the dry lab. And

Speaker:

we have our own internal, and so we work in two spaces, two

Speaker:

major areas. One is biologics, which includes antibodies,

Speaker:

which includes immunocytokines, and we have an internal pipeline

Speaker:

for immunocytokines. And we also work in

Speaker:

another area called targeted protein degradation or TPD.

Speaker:

And there we are doing a novel target discovery

Speaker:

and that can be used for small molecules. So we have signed

Speaker:

deals in both of these in molecular glues, as they

Speaker:

And when you're doing deals and thinking about partnerships, so

Speaker:

I'm assuming these are with mostly bigger companies. Are they with

Speaker:

academic institutions? Kind of what's the makeup of your deals and

Speaker:

Mostly bigger companies, bigger pharma companies, the

Speaker:

deals we have done. We've also worked with academic or

Speaker:

nonprofit institutions, like we have worked with the Bill and Melinda Gates

Speaker:

Foundation. We are currently working with Lawrence Livermore

Speaker:

National Laboratory, but Big Pharma. We are also very

Speaker:

interested in working with biotechs and, you know, same-sized

Speaker:

companies. I mean, they have synergistic complementary technologies

Speaker:

and we can work together to co-develop something. So

Speaker:

we are pretty open with the type of partners that

Speaker:

So on a personal note, I'm really interested in your answer to

Speaker:

this. One of the things that we talk about sometimes is networking and

Speaker:

the importance of networking. And I feel as though a large portion of your job

Speaker:

has to be just putting yourself out there and networking with

Speaker:

a variety of stakeholders. Does this come naturally to

Speaker:

you or is this a skill that you've honed over time or have you always just

Speaker:

been like, I'm totally cool to meet everyone. It's fine. Because

Speaker:

Yeah, yeah, yeah. It comes naturally to me and

Speaker:

which was one of the reasons I felt I couldn't sit

Speaker:

at the bench and do my own research. I was more

Speaker:

a people's person i wanted to be part of teams and so right

Speaker:

after my phd it was a conscious decision because of my

Speaker:

personality to move and be in such an extrovert and

Speaker:

enjoy so much being in teams and companies so networking

Speaker:

comes very naturally i get a lot of energy going into a

Speaker:

room not knowing anyone and you know shaking hands introducing

Speaker:

myself and making 15, 20, 30 friends, new

Speaker:

contacts, and then following up with them. And my project management skills

Speaker:

over 10 years have really taught me how you want follow

Speaker:

up and get organized. So networking comes

Speaker:

Well, I think that's a great way to phrase it though. You come out with like 15 to

Speaker:

20 friends. That's like the best way to think about going into a networking event, but

Speaker:

you're just like making new friends. Everyone thinks of it as like, oh, it's a business thing,

Speaker:

And I really truly also believe in building relationships. You

Speaker:

don't go into a room because you want to make a deal. You go in there to

Speaker:

have fun and to make friends and to give and

Speaker:

to want to help them. Right. And then along the process,

Speaker:

there are so many contacts and we have been in touch for two, three

Speaker:

years and nothing has come out from there. No deal has

Speaker:

come out. And then now I also, you know, again,

Speaker:

with being coached and, you know, I now find I

Speaker:

really look to see how can I help these people, you know, maybe the 30 minute

Speaker:

call or, you know, something else I can do, make, help

Speaker:

them connect to somebody else. And who knows, you know, all good you

Speaker:

Yeah, I think that's a fantastic point. We have a candidate education

Speaker:

platform where we help candidates with either transitioning into biotech

Speaker:

or getting that next job. And we did a little ask a recruiter event yesterday.

Speaker:

It was all about networking. And so I have two follow

Speaker:

on questions for that. I am not an extrovert. I'm actually

Speaker:

quite introverted. The definition of that for people who maybe don't

Speaker:

know is exactly what you said. You get energy from going into those rooms.

Speaker:

I come out really drained. It's not that I don't enjoy myself, but it's

Speaker:

a bit of an energy suck for me, but just like myself out to go into

Speaker:

those rooms. It is hard for me still. And so I remember when

Speaker:

I finished my PhD and I started this consulting firm, I knew I had to

Speaker:

network. So my secret weapon was I joined

Speaker:

Women in Bio and I volunteered to be a chair of one

Speaker:

of the committees because that gave me almost a platform where

Speaker:

I had to network, but I had a reason. I had an agenda, right? We were planning

Speaker:

events and we were doing all these things, so I had to reach out. So I see

Speaker:

that you're involved with Women in Bio too. It's a fantastic organization. Do

Speaker:

you find that your networking is easier because of that and having that bit of a platform?

Speaker:

Yeah, no, platforms are very, very helpful. And I love Women

Speaker:

in Bio. You know, I'm the SoCal chair for the Executive Women

Speaker:

in Bio. And I completely agree with you.

Speaker:

I'm also part of Boost by BioBreak. There again, we come in

Speaker:

with a common purpose, common theme, and

Speaker:

networking is easy, much, much easy there. And,

Speaker:

you know, similarly, when we go into, you know, receptions or whatever,

Speaker:

Genentech, let's say, is bringing together you know, all their

Speaker:

partners, everyone together, it becomes easier because you

Speaker:

have a common life sciences talk. So certainly

Speaker:

the platforms make it so much easier for networking. The

Speaker:

big thing is to put yourself out there to become members of

Speaker:

And there are just, they're fantastic. You do have to sort of live in

Speaker:

a hub where for some of these, there are some online ones, but Women

Speaker:

in Bio particularly, there's a lot of in-person events and they're sort of in those

Speaker:

science hubs, but Fantastic group. And so

Speaker:

my second follow on was about you're coming at

Speaker:

this from a place of service, not from a place of what can

Speaker:

this person do for me, but how can I be the facilitator? And

Speaker:

we talked about that a bit yesterday too. So can you outline, you

Speaker:

know, you said making connections for people, having calls with people,

Speaker:

what are the sort of ways that you offer up your service during

Speaker:

People know my trajectory and where I have gone. So I will

Speaker:

have a lot of young women who are like, wow, I like the career transitions

Speaker:

you have made. Can I talk to you for like 30 minutes, like

Speaker:

more mentoring type of a thing. So career mentoring, whatever,

Speaker:

I have done that. On the business side, people will usually say,

Speaker:

all right, can you make a connection? I'm trying to reach so and so person in this

Speaker:

company. And so, you know, that's a connection that I would do. On

Speaker:

the strictly BD side, people will also say, you know, I'm trying

Speaker:

to do this deal. And, you know, how do you navigate terms for

Speaker:

this deal? And without revealing anything confidential, I can

Speaker:

still have a good conversation with them. So multiple different

Speaker:

areas in which, you know, you really can. I'm

Speaker:

aligning with a lot of people now for women

Speaker:

who are looking for board roles. And say, okay, how do

Speaker:

you navigate that? And I have gotten from people who

Speaker:

are way more experienced and veterans and, you

Speaker:

know, and as I go through and understand this process, I

Speaker:

am happy to share the same on that topic for women who

Speaker:

are just joining their journey. So multiple

Speaker:

ways that you can totally give something. You

Speaker:

just have to talk for 10 minutes and you can figure out, all right, this is what's

Speaker:

in common. And then open up a little bit more and you will

Speaker:

know what they need. And then, you know, you focus on that. And

Speaker:

certainly I'll always put myself out there and say, okay, this is what I

Speaker:

am looking for. Or I'm not able to get access to so and so company

Speaker:

or how did you do that? So it's. A little research to

Speaker:

see, all right, where they have gone, how they have gone. LinkedIn is

Speaker:

a beautiful resource. And then take it from there. The

Speaker:

follow-ons are good, you know, take time for a coffee, happy

Speaker:

hour, whatever we need to do. We're all busy, but hopefully more in-person

Speaker:

If not, Zoom is always good. I love a good in-person meeting.

Speaker:

I think I'm somewhere in between the two of you. I find a good event is

Speaker:

like just rejuvenating enough. I can't do them all the time, but

Speaker:

I do love getting out there to network a little bit. So I see so many

Speaker:

people who have been or they are active on boards, and

Speaker:

if someone wants to join a board, how do they go about that? What is

Speaker:

It depends, public company boards versus private company boards. I

Speaker:

can speak more for private company boards, but a lot of

Speaker:

it really comes from your network, right? What skillsets you have,

Speaker:

what are they looking for? What's the synergy? That is always

Speaker:

important. And after that, they're looking for people within

Speaker:

their network to see what value they can bring. So

Speaker:

it's always your experience and what you have to offer.

Speaker:

and how it is applicable to what they need.

Speaker:

And, you know, as early stage companies move through their journey,

Speaker:

even in the first three, four years, you know, their needs change dramatically.

Speaker:

So at some point in time, maybe you're looking for connections for GetBC funding.

Speaker:

Then you're looking for connections to get some partnerships done. You

Speaker:

need connections or you need ability to go back and forth.

Speaker:

You need a founding board to talk about your technology and

Speaker:

what products you want to put, like, you know, your roadmap, your technology roadmap.

Speaker:

So it depends on what the company needs and then they

Speaker:

will put a skills matrix and say, okay, these are the skills

Speaker:

that I am looking for. And then they look for board

Speaker:

members and some use consultants and recruiters, but many a

Speaker:

time from what I have heard, it's usually through your

Speaker:

network. And again, your network can be, you know, your first level,

Speaker:

second level, you know, you know, everybody within like three levels or four levels anyway.

Speaker:

With that, how have the needs of boards changed today

Speaker:

versus just a few years ago? I know we've gone through a lot of changes

Speaker:

globally and also with funding. Now, what are you

Speaker:

Boards certainly have changed, you know, certainly

Speaker:

with the diversity. There is a lot of recognition for diversity and

Speaker:

this is gender, age, ethnic groups, race,

Speaker:

all of those. So definitely diversity wise i'm

Speaker:

in public company boards have even mandated that they need so many

Speaker:

women representatives and other diversity classes included

Speaker:

for private company boards so there's enough research and

Speaker:

enough studies out there to show that if you have a divorce board

Speaker:

it's a more productive and efficient board. I see a huge increase

Speaker:

also in independent board members. So you

Speaker:

obviously have your company executors, your founders, co-founders who

Speaker:

hold board seats, your investors who will hold board

Speaker:

seats, and both of them have vested interests for what they want

Speaker:

to do. And so there is a big role for independent board members

Speaker:

to really bring in a complete outside perspective. And

Speaker:

then the value of the board and

Speaker:

you know how they can really bring the whole board

Speaker:

governance from what I see and hear has

Speaker:

been formalized a lot more right. Boards used

Speaker:

to run for. meetings once every quarter

Speaker:

or whatever, now they are more diligent. The expectations from

Speaker:

board members is more. The way board meetings

Speaker:

are run are different and very methodical and very

Speaker:

efficient to get the maximum value out of it. So I believe because

Speaker:

of diversity, because of independent board members and

Speaker:

just the way board meetings are held, boards

Speaker:

Kind of switching back into talking about sort of the more day-to-day aspects

Speaker:

of your job. I'm curious about how you market a

Speaker:

bioscience company when you are pitching to investors. Do

Speaker:

you have any tips or tricks that you could share with everyone about

Speaker:

some key things people should know about when they are ready to get to the point of selling

Speaker:

Yes, it's all about the science, right? So it is, what's

Speaker:

the technology? You may not have a product, right? You're too early to have a product,

Speaker:

but what's the science? And it's all about the product and

Speaker:

the market fit. So what is your product? You're hammered.

Speaker:

And what are you going to solve? Right? And so the product market

Speaker:

fit and showing that is super, super important for the investors. At

Speaker:

the very earliest stages, at the seed round. This is

Speaker:

my technology. Here is the competition. Here is how I'm better

Speaker:

differentiated compared to the competition. And this is

Speaker:

what I'm going to do. This is a problem in the world that I'm going to solve.

Speaker:

Right. And I'm making a diagnostic that will, you

Speaker:

know, detect something earlier or detect something at

Speaker:

a different stage. Or I have a research technology that

Speaker:

will enable all these big pharma companies to discover this

Speaker:

or, you know, sooner or faster or something like that. So you

Speaker:

need to have your value prop, right? Very, very clear.

Speaker:

And the value prop will ride on your technology. It

Speaker:

will ride on your differentiation and what problem you're

Speaker:

going to solve. So I think those are the critical. And then

Speaker:

after that, of course, how much money you're going to raise, how you're going to use

Speaker:

that money, how long it's going to take you. Really a very good execution

Speaker:

plan. And what point will you reach before you need

Speaker:

more funding? What will we deliver? What milestones will

Speaker:

you hit from a science perspective, you know, from taking

Speaker:

product testing, whatever your milestones before you made the next

Speaker:

round of funding. Investors do not want, and they want to see

Speaker:

very crystal clear these things. They do not want

Speaker:

to see markets where you say, oh, this market size is

Speaker:

like a trillion people. They want grounded and

Speaker:

well thought of, backed up by research, backed up

Speaker:

by studies, backed up by data. So key

Speaker:

slides, but what your science can do, how you're going

Speaker:

to make it a product, what you're going to solve, how much money you

Speaker:

need, and what you're going to do with the money. So

Speaker:

deep, deep clarity. Deep clarity. Yeah. And

Speaker:

you want to go multiple, multiple iterations. Your first one

Speaker:

is never going to be the best one. I have known business plans

Speaker:

and investor decks, which have started with a one idea and

Speaker:

completely moved over upon discussing with a

Speaker:

few investors because they were trying to solve a

Speaker:

wrong problem. You know, your science hasn't changed, but what you

Speaker:

were trying to, you know, direct it towards was not

Speaker:

the best one. And upon feedback, consistent feedback, You know,

Speaker:

what we were thinking was not really right. We got to do this. And

Speaker:

then it immediately makes sense. And, you know, and so

Speaker:

I would suggest going to a few investors that you do not, your very

Speaker:

first slide decks to go to investors you don't expect to make deal.

Speaker:

I wouldn't want to go to the ones that you are expecting because that

Speaker:

Well, that's really good advice, though, to anyone listening to this. Like, don't be disheartened

Speaker:

that your first ones are kind of not great, but also maybe don't pitch them to like

Speaker:

I wouldn't say don't pitch it to your dream team and certainly don't

Speaker:

be disappointed because you'll be kissing a lot of frogs.

Speaker:

We've interviewed quite a few people who look at DEX from VC

Speaker:

folks to consultants that work on the strategy side. And

Speaker:

the universal complaint is that slide decks

Speaker:

are pretty much always terrible when they start out. And it's so important because

Speaker:

that's really the thing that has to tell your story. Yeah,

Speaker:

you might get the luxury of standing up and telling your story alongside your

Speaker:

deck, but a lot of the time it needs to stand alone. It needs to stand on

Speaker:

And I would also say, and I know that's what co-founders that

Speaker:

I work with at A Alpha Bio and also previous companies have,

Speaker:

is Surround yourself with mentors, surround yourself with

Speaker:

advisors, you know, scientific advisors, business advisors, legal

Speaker:

advisors, any type of advisors that you can surround yourself

Speaker:

because that will, it's such a steep learning curve

Speaker:

and it is so worth it, right? Because you will continue,

Speaker:

you'll learn a lot. And so I think advisors, I mean, I live and

Speaker:

die by mentors and always my entire career.

Speaker:

I have, I'm going to have two, three, up to six mentors at a

Speaker:

When you talk about, you're gonna have to kiss some frogs and expect

Speaker:

that the first ones aren't going to be great. I think the really important thing here

Speaker:

is that you've had a really successful career and you've done some absolutely

Speaker:

incredible things, but everyone does have some failures, right?

Speaker:

I mean, it happens to the absolute best of us. So do you have any

Speaker:

Yes, I think unless again there are epic failures

Speaker:

maybe but most of the failures will teach you right

Speaker:

you come out of it. I mean I have had places or

Speaker:

roles that I wasn't super excited about and

Speaker:

I hated it during the time but when I came out of it. I

Speaker:

felt I would go back and do that again to

Speaker:

learn what I learned and to better understand for myself what

Speaker:

I like and what I don't like. Right. So I think anything is

Speaker:

really failure, failure, but you make the best judgment at

Speaker:

the time that you are in. But every failure teaches

Speaker:

you so much more on how to navigate.

Speaker:

You just have to go through it. That's what I tell my kids.

Speaker:

You just have to go through it, come out on the other side, and

Speaker:

That's right. Full of hard knocks, always.

Speaker:

It's so true. So when you're thinking about collaborations

Speaker:

and business partnerships and mentors and things like that, where

Speaker:

are you thinking about getting those and what stage are you

Speaker:

thinking about getting those mentors and collaborators in

Speaker:

your startup journey? So if you have a really, really new startup, when's

Speaker:

So you are starting from day one that you incorporated a

Speaker:

company or even before. Right. So you are you have a technology coming

Speaker:

out of academia. You are already looking at collaborators

Speaker:

and partners. Now you haven't had a dedicated business development

Speaker:

person at that time, but you as the co-founder, and I can say

Speaker:

that for our co-founder and CEO who had the

Speaker:

beady hat, and he continues to have the beady hat together with me at

Speaker:

this time, but you are thinking collaborations and

Speaker:

mentors even before you are thinking of incorporating the

Speaker:

company. Then you need to decide how much

Speaker:

is collaborations and VD part of your company strategy.

Speaker:

Are you going 100% partnerships or

Speaker:

are you doing internal development and part partnerships or

Speaker:

are you not going to do partnerships and really focus on select therapeutics

Speaker:

or products you want to build internally. And I'm talking more about a platform

Speaker:

company. Then majority of the people will come in

Speaker:

prior to a series A or right after a seed round, sometime

Speaker:

between seed round and a series A. That's when

Speaker:

a dedicated BD person can come. But BD efforts are

Speaker:

starting way before you even started a company. Because BD collaborations

Speaker:

will do a couple of things. One, they will de-risk. your platform, right?

Speaker:

So they're doing one work. It's an outside party. They will validate your

Speaker:

platform, right? They will give you the awareness you need. You

Speaker:

can publish together, you can do press release. So they do so

Speaker:

much that you could be drinking your own Kool-Aid for

Speaker:

10 years, right? So that's what collaboration is. And of course, they

Speaker:

bring in revenue, which is always good. So Beedi starts

Speaker:

Yeah, that's really interesting. I don't think a lot of founders coming out of academia

Speaker:

really are thinking in that way. So it's really good to hear that

Speaker:

articulated in that way, because people think of business development

Speaker:

as like a really late stage thing a lot of the time, but it's

Speaker:

so true. You talked about alliance managers earlier on,

Speaker:

and that is a career path that a lot of scientists don't really

Speaker:

know about. But that sort of gets you exposure to that partnership aspect.

Speaker:

More academics actually really should think about what are the partnership aspects

Speaker:

That is so true because they really think if I do cool science,

Speaker:

they will come. But that's not true. You know, you

Speaker:

can do cool science, but you do have to talk about your science. You

Speaker:

have to build those networks and those relationships before

Speaker:

they will come. You have to wear the two hats. You have to keep doing

Speaker:

your science as you know, we say, you know, you have to build

Speaker:

your plane, you have to fly your plane, you have to sell your plane, got to do them

Speaker:

Well, let's pull that thread though for anyone who's listening, who might be like,

Speaker:

wow, that actually sounds really cool. Like I'm a scientist and I think business

Speaker:

development sounds neat, but like, how do I get there? What would be the

Speaker:

best steps for someone to maybe start exploring or to take if

Speaker:

I love scientists going into B.D. and more and more so

Speaker:

in life sciences, you would see most of the people in

Speaker:

B.D. come from a science background. So I have a Ph.D. I

Speaker:

have an MBA. I think I consider my Ph.D. more valuable than

Speaker:

the MBA. And because I interact with scientists on

Speaker:

both the sides, you know, in here, as I develop the value proposition on

Speaker:

the other side, as I understand the needs of my partners. So

Speaker:

for all scientists, it is to take your science and

Speaker:

socialize that with potential collaborators. And this

Speaker:

may be academic collaborators. These may be VCs. These may be pharma

Speaker:

companies. There may be other biotech companies. There are so many ways to

Speaker:

make a deal. But it all starts with you talking about your

Speaker:

science and your ideas with the partner. and

Speaker:

then understanding what they need. Many

Speaker:

a time, the science we do comes from ideas or

Speaker:

needs that the pharma partner want. You call it the voice of the

Speaker:

customer. So it is super, super important for the scientists

Speaker:

not only to do the science and communicate what

Speaker:

they're looking to do with the outside world, but

Speaker:

also to have those discussions to really understand what

Speaker:

is it that the companies need, the collaborators need, And

Speaker:

then see, oh, can I change something here to address

Speaker:

that need? Right. And if I do that, can

Speaker:

I make a partnership or a collaboration or a deal with this

Speaker:

particular company? You have to go both ways. Super important.

Speaker:

And as you're thinking about building your team internally, whether

Speaker:

it's in BD or your adjacent verticals, are you

Speaker:

looking for those scientists that are kind of up and coming? How

Speaker:

Yes, I do like scientists. It's easier. They

Speaker:

spend so many years. They know the science. It's easy for them, even

Speaker:

if it's not the same field that they did their work in, for them to quickly pick

Speaker:

up technology and science. But mostly I'm also looking

Speaker:

for, do they have the drive? Do they have the, you know, fire on the belly? Currently

Speaker:

I have alliance management that reports to me. I also have communications,

Speaker:

scientific and marketing communications reporting to me. And both these

Speaker:

teams are very driven in science and are

Speaker:

Is Engel Fabio, are you fully remote or hybrid or are

Speaker:

So we are based in Seattle and we

Speaker:

have a large team that comes to work five days

Speaker:

a week, you know, because they're involved in lab work and we

Speaker:

have a portion of our company that does hybrid work. So

Speaker:

many of them would come in at least three days a week. And

Speaker:

usually Wednesdays are our day where pretty much the whole company comes

Speaker:

together. We have lots of internal meetings, everything, happy

Speaker:

hours and all of that happen on Wednesdays because majority

Speaker:

of the team will be there on Wednesdays. And then we have few, a

Speaker:

very small fraction of employees who are remote and

Speaker:

they will come in at least twice a year, if not more. I

Speaker:

love that we have two onsite events, one

Speaker:

in January and one in July when we

Speaker:

get entire company together for a whole week. And

Speaker:

we celebrate, we strategize, we develop objectives.

Speaker:

Oh, I love our culture here. We like to talk about communication on

Speaker:

this show a little bit as well. And so you said your communication

Speaker:

team reports into you, so that's kind of perfect. But with the teams

Speaker:

that are hybrid, on-site, remote, all of those things, do you have

Speaker:

any communication strategies that have worked particularly well for internal communications?

Speaker:

Yeah. And again, we are very proud of the culture we are

Speaker:

building at A Alpha and how we want to continue to

Speaker:

maintain this culture. We have weekly all hands meeting. So,

Speaker:

you know, our CEO will drive it and we go over our values.

Speaker:

We give kudos to people when they want to give a shout

Speaker:

out to somebody for living up some of the values. We have

Speaker:

announcements for birthdays. We have any business updates that

Speaker:

we want to do. Once a month we have objectives, how

Speaker:

we are progressing across our company and department objectives.

Speaker:

We call those OKR meetings. So we have the weekly meetings, we

Speaker:

have the monthly business meetings. We also do

Speaker:

social events to get everybody together, you know,

Speaker:

and communicate happy hours once a month. Internal communication Slack

Speaker:

is a great tool. We use that and we have so many channels and

Speaker:

we, you know, as we grow so quickly, right. You know,

Speaker:

we were like, I was employee number 15 or something like that two

Speaker:

years ago and we have 50 people. So we have grown quickly.

Speaker:

So the communication is very key and it's very intentional, right? You

Speaker:

That's fantastic. So for investors, like I know we talked about being super

Speaker:

clear and everything, but I guess one of the things is like, could you take us through

Speaker:

kind of like what that sometimes looks like from start to finish? Like you

Speaker:

do your initial pitch and then, you know, what happens from there?

Speaker:

I think people, you know, we talk about a lot, but I don't think we provide a ton of

Speaker:

clarity into like what really goes on behind the scenes when you're structuring a

Speaker:

Yeah. So for a VC, for funding, you know,

Speaker:

different from like a partnership deal, which are, which are different agreements, but

Speaker:

you first need to know your plan, how much money you need. And

Speaker:

this is down to putting your entire budget together. Let's say you're

Speaker:

going to take 24 months to go from point A to point B, right.

Speaker:

And you want money in point A and you'll get to point B. You

Speaker:

really need to know, and this is called use of funds. And you really

Speaker:

need to put a very detailed plan to know how

Speaker:

much money you need and how you're going to spend it and

Speaker:

where you're going to get. And so that is like your background Excel that

Speaker:

drives the dollar value that you are looking to raise. And

Speaker:

so you need to have that, you know, and then you put it

Speaker:

down in deliverables and say, OK, I need so much money

Speaker:

to get to these three milestones. And

Speaker:

so you do your science, you talk about the market, you

Speaker:

talk about how great you are from a market differentiation

Speaker:

and all that piece. You talk where your competitors are and how you're

Speaker:

good. Then when it comes to money, you have done

Speaker:

your homework. to know, to keep your lights on,

Speaker:

to everything, you know, your research budget, to

Speaker:

how many people you're going to hire and what they're going to cost, what levels. It's

Speaker:

a very, very detailed way by which you have estimated

Speaker:

how much money you need. Obviously you're going to put some buffer

Speaker:

to that because things change and then you get your

Speaker:

number to say, I need so much money for me to get

Speaker:

from point A to point B. And what I'm going to deliver to

Speaker:

you, if you fund me with this, is I'm going to be at this stage. I'll

Speaker:

have an alpha version, or I'll have a beta version, or I will sign

Speaker:

two partnerships where they will have validated, you

Speaker:

know, my technology, or I will have finished this animal studies,

Speaker:

right, to take this candidates so much further. So

Speaker:

depending on whichever area, be it diagnostics, research technologies, or

Speaker:

therapeutics, there are very clear milestones

Speaker:

that you need to move to, to know what you're going

Speaker:

to do. And all investors know, because they are sitting in either one

Speaker:

of these portals, right? They're either in funding platform and

Speaker:

research technologies, or they're into diagnostics, or they're after therapeutics

Speaker:

or they are about, you know, services or whatever it may be,

Speaker:

they know exactly what this pipeline of

Speaker:

events looks like. And you have to be as good there

Speaker:

and speak their language. So if you say, I need five million dollars and

Speaker:

It's really interesting. I think a lot of people graduate from their

Speaker:

PhD and they have a great idea and they

Speaker:

want to found a company, but what does that roadmap look like? And without

Speaker:

experts to help you understand all

Speaker:

of those different costs, what we see often is that there are

Speaker:

some incubators that are attached to schools often, like MIT

Speaker:

has a pretty well-known one and they'll give a bolus of funding, but not

Speaker:

a lot of parameters around that. And so we've got first

Speaker:

time founders sometimes that are a bit adrift and they think I have

Speaker:

all this money and it's like, well, that's not very much money. We have to actually really

Speaker:

plan out what is your next step and you need to have that in place. So I

Speaker:

think experts, you know, like you and folks that can really understand

Speaker:

how we craft this message, how do you get that budget, all

Speaker:

of those things. That's so essential at the early stage. It is

Speaker:

I'm proud of several universities who have commercial

Speaker:

arms with amazing business advisors. I know UW does,

Speaker:

right? Who can help you with that? They have programs and

Speaker:

there's creative destruction labs who has multiple sites. I

Speaker:

mean, I sit there as a business advisor. There are

Speaker:

resources. You have to go out and, you know, seek

Speaker:

many of these business advisors and take your Excel

Speaker:

and then say, does it making sense? Is it making sense before you go to

Speaker:

Yeah, it's such a path. It is, it is really interesting. And the,

Speaker:

the number of hats you have to learn to wear as a biotech founder, it's

Speaker:

It is amazing. Yeah, it is staggering. It's an amazing, amazing

Speaker:

growth curve. I have a lot of respect. And a little bit

Speaker:

of envy that I was never that co-founder.

Speaker:

I sit right behind the co-founders always and I enjoy my

Speaker:

role. I love my role. But I have so much respect for co-founders coming

Speaker:

out of academia with their PhD thesis and

Speaker:

Well, I'm curious, you had to talk about a couple of contributions that

Speaker:

you're the most proud of and things that you think have just been the coolest things

Speaker:

Yeah. A lot of it was, you know, I'm

Speaker:

more excited about my work in early stage companies than

Speaker:

at the Pfizer or the big life technologies. One

Speaker:

of my very earlier companies was BD, huge company, but

Speaker:

there was part of portfolio management where we went into

Speaker:

a whole new area and wanted to launch like 250 research

Speaker:

reagents. And so I'm very excited. This was many, many years

Speaker:

ago. We scoured the literature, we made a deal

Speaker:

to get access to those antibodies. They were very

Speaker:

novel. We did the R&D we needed to do, put it

Speaker:

into manufacturing production. That was all my project management role. And

Speaker:

within six to nine months, we had 215 novel

Speaker:

antibodies we put on the market. for research. This was for research used

Speaker:

to enable pharma and all that. So that was one of my very earliest

Speaker:

projects I still speak very fondly about. At

Speaker:

Precision Nanosystems, where I was, I am very

Speaker:

proud of being able to get about $40 million

Speaker:

in funding from the government of Canada. And this was part of

Speaker:

the COVID pandemic. Canada was looking

Speaker:

for more you know, in-country establishment and to

Speaker:

nurture technology. So we did two separate deals with

Speaker:

the government of Canada. One to build a manufacturing facility. The

Speaker:

other one was to move a particular technology and product forward.

Speaker:

So I was very excited to be able to secure that funding. And at

Speaker:

Alfa Bario, I'm very excited to have been able to do three

Speaker:

big partnerships in this market environment with big pharma,

Speaker:

Yeah, this is a tough market. I would definitely be proud of that too. Well,

Speaker:

we have a few closing questions. So we always like

Speaker:

to kind of bring the career question full circle. You've done

Speaker:

some awesome things. And so what's left for you to accomplish?

Speaker:

I love business development. I really do. I like working with co-founders,

Speaker:

enabling technology, roadmap, strategy, and

Speaker:

building company value. Love this. I don't think I'll ever go

Speaker:

back to Big Pharma ever. To work. And going forward,

Speaker:

I think I'm looking forward more to give. And as

Speaker:

an advisor, right, as a mentor, I'm

Speaker:

certainly interested in board service. right, for, again, early stage

Speaker:

companies. So I think next journey, while I continue my

Speaker:

work, I'm really looking for some board roles. And I can see

Speaker:

myself there where I can really enable and impact so

Speaker:

Well, everyone who listened to the show knows that this question is coming because

Speaker:

we ask it to every person. It's my favorite question. What

Speaker:

is your favorite book or a book that you think everyone should read? My

Speaker:

I'm going to sell two books, one that I would like everybody to read, and

Speaker:

the other one is my personal favorite, which is also a good book to

Speaker:

read. The book I read this last year, and it is Let My

Speaker:

People Go Surfing. And this is the book by Von

Speaker:

Schwingart. I think he's the founder of Patagonia.

Speaker:

I love the book. Loved the book and just his career

Speaker:

trajectory and just the way a reluctant

Speaker:

business person as they call him. And he just went

Speaker:

on to make the biggest sustainable

Speaker:

company from something he needed for himself as

Speaker:

he wanted to go mountain climbing. And so phenomenal book,

Speaker:

really, really loved how he passionate about adventure

Speaker:

and what he wanted to do. And then he needed the tools, which nobody had. So

Speaker:

he started a company to do it. Then he expanded for all

Speaker:

the adventurous stuff that he liked to do and then go beyond and

Speaker:

then made a massively profitable company and then donated

Speaker:

it all to foundation and said, this is all for the good of earth.

Speaker:

I am so impressed. I love that book and I've been following him

Speaker:

since. So that's one book. The book that I really do

Speaker:

recommend for everyone, which is also one of my personal favorites, it's

Speaker:

called The Present. It's an old book. It's an easy

Speaker:

read. I cannot even remember the name of the author, but you can look it up. It's just

Speaker:

called The Present. It's a phenomenal book of

Speaker:

how you want to think yourself about, you know, the past, the present,

Speaker:

the future. So it's an easy read, like a 30 minute read, but

Speaker:

it's a book I keep going back to every time I'm feeling no

Speaker:

or anytime I want a little motivation. I

Speaker:

know the whole book, but I still enjoy going

Speaker:

through the book and just how beautifully it's written. So beautiful book.

Speaker:

Oh, those are awesome suggestions. I haven't heard of either one of those and

Speaker:

Where can people reach out to you if they want to learn more or

Speaker:

I'm always on LinkedIn. It's my newspaper in the morning. Um,

Speaker:

I live in San Diego. Uh, you know, my, the company is

Speaker:

in Seattle, so I'm in all the networking thing,

Speaker:

but easiest way is just hit me up on LinkedIn and I

Speaker:

Awesome. Well, thank you so much. This was so much fun. I learned

Follow

Links

Chapters

Video

More from YouTube